Is Earth Science Tech, Inc. a good investment? Earth Science Tech, Inc. (ETST) is currently trading at 0.0952 USD.
In terms of valuation, the stock trades at a P/E ratio of 10.40. This relatively low multiple may signal that Earth Science Tech, Inc. is undervalued compared to historical market norms.
Earnings Schedule: Earth Science Tech, Inc. is expected to release its next earnings report on Nov. 11, 2026. The market consensus estimate for Forward EPS is 0.04.
No, it does not currently pay a dividend.
Earth Science Tech, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Nov. 11, 2026. The company currently has a trailing EPS of 0.01.
Earth Science Tech, Inc., together with its subsidies, focuses on health and wellness industry. It engages in vertically integrated healthcare platforms that combines compounding pharmacy operations, telemedicine platforms, clinical support, and patient fulfillment. It is also involved in investments in real estate and asset management activities, and consumer products business. It also operates multi-state sterile non-sterile compounding for specialized therapies through RxCompoundStore.com; mister meds sterile and hazardous compounding center under the Mister Meds name; frictionless asynchronous consults funneling to licensed pharmacies; under the Peaks Curative brand name; virtual care brand for home-based therapies under the DOConsultations brand name; and brick-and-mortar healthcare facility under the Villas Health Care brand name. In addition, it is involved in the development, asset management, and financing under the Avenvi brand name; and provides direct-to-consumer retail under the MagneChef brand name. The company was formerly known as Ultimate Novelty Sports, Inc. and changed its name to Earth Science Tech, Inc. in March 2014. Earth Science Tech, Inc. was incorporated in 2010 and is headquartered in Miami, Florida.
Community Discussion